Pravastatin sodium
- Product NDC
- 68071-2194
- 11-digit product format
- 680712194
- Labeler code
- 68071
- Product ID
- 68071-2194_445b6d9f-4fdf-420c-e054-00144ff8d46c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pravastatin sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals, Inc.
- Application
- ANDA076939
- Marketing category
- ANDA
- Marketing start
- 2006-10-23
- Marketing end
- 0000-00-00
- Substance
- PRAVASTATIN SODIUM
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-2194-3 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |
| 68071-2194-6 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |
| 68071-2194-9 | 2020-05-05 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |
| 68071-2194-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |
| 68071-2194-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |
| 68071-2194-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-04c5-f424-e053-dadaa90a57ce | 445b6872-4322-24b6-e054-00144ff8d46c |